BeatO
India
- New Delhi, New Delhi
- 21/11/2022
- Series B
- $33,000,000
Control Diabetes with Experts!
- Industry Hospital & Health Care
- Website https://www.beatoapp.com/
- LinkedIn https://www.linkedin.com/company/beato-health-arx-technologies-pvt-ltd/
Related People
Gautam ChopraFounder
India -
Delhi
In 2015, I embarked on a journey to empower people with Diabetes with tools that can help them manage their sugar levels.
BeatO, short for beat diabetes (the 'O' being the ring of diabetes), is a mobile platform that motivates a diabetic to increase compliance and reduce their out of pocket expense.
Our small and nimble health and tech focused team comprises top talent that brings in the passion and desire to roll out the best user experience for a diabetic in managing their ailment. In our core team (tech & business), we have Type 1 and Type 2 diabetics, with real life practical know-how of diabetes and how to beat it.
Check out our Android App by clicking this link:
https://play.google.com/store/apps/details?id=com.healtharx.beato
And Like our Facebook page:
WWW.Facebook.com/beatoapp/
Before BeatO, I was in Europe for the last 6 years where I led several commercial initiatives within the airline sector.
Prior to that, I completed my MBA from the Indian School of Business, Hyderabad.
I am an avid traveler who is passionate about exploring world cuisines. I regularly play squash and am a keen Golfer.
I am fluent in English and Hindi, and intermediate level in German.
Leona Health | $14,000,000 | (Dec 18, 2025)
Limenet | $8,217,860 | (Dec 18, 2025)
Codoxo | $35,000,000 | (Dec 18, 2025)
Drive Health | $15,000,000 | (Dec 18, 2025)
DataLane | $22,500,000 | (Dec 18, 2025)
Addition Therapeutics | $100,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)
Scylos | $3,000,000 | (Dec 18, 2025)
Last Energy | $100,000,000 | (Dec 18, 2025)
Navier AI | $6,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)